The hypoxia pathway is a fundamental cellular response to low oxygen levels. It regulates crucial processes such as angiogenesis, metabolism, and cell survival.
Hypoxia-inducible factors (HIFs) play a central role by activating genes that help cells adapt to oxygen deficiency. Dysregulation of this pathway is associated with cancer progression, ischemic diseases, and other pathological conditions.
Why Choose AnyGenes® for Hypoxia Pathway Research?
AnyGenes® provides advanced qPCR arrays tailored for studying the hypoxia pathway. Our solutions empower researchers to:
Investigate key regulators like HIF-1α, VEGF, and EPO.
Analyze changes in gene expression during oxygen scarcity.
Explore the interactions between oxygen regulation and other signaling pathways, such as PI3K/Akt and mTOR.
Our qPCR arrays are designed for precision, reproducibility, and reliability, enabling you to uncover novel insights into the molecular mechanisms of oxygen deprivation.
Hypoxia-inducible factor (HIF) regulation during normoxia and hypoxia.
KEY MECHANISMS IN THE HYPOXIA PATHWAY
HIF Activation: Under low oxygen conditions, HIF-1α stabilizes and dimerizes with HIF-1β, activating target genes involved in angiogenesis, metabolism, and survival.
Angiogenesis Regulation: VEGF and other factors are upregulated to promote the formation of new blood vessels and restore oxygen supply.
Metabolic Adaptation: Oxygen scarcity triggers a metabolic shift to glycolysis to sustain energy production.
Crosstalk with Other Pathways: Interactions with signaling pathways like PI3K/Akt and Wnt highlight the complexity of cellular responses to oxygen reduction.
BIOLOGICAL FUNCTIONS OF THE OXYGEN SIGNALING PATHWAY
Oxygen regulation is vital for:
Oxygen Homeostasis: Regulating cellular adaptation to low oxygen levels.
Angiogenesis: Promoting blood vessel formation to restore oxygen supply.
Metabolic Reprogramming: Supporting cell survival during hypoxic stress.
Tumor Progression: Enhancing cancer cell survival, angiogenesis, and metastasis.
Ischemic Tissue Repair: Facilitating recovery in conditions such as stroke and myocardial infarction.
DISEASES LINKED TO OXYGEN DEFICIENCY SIGNALING
Dysfunctions in oxygen-sensing mechanisms are implicated in:
Cancer: HIF-driven responses support tumor growth, angiogenesis, and resistance to therapy.
Ischemic Disorders: Oxygen deprivation contributes to tissue injury and repair in strokes, heart attacks, and other conditions.
Chronic Respiratory Diseases: Persistent low oxygen levels alter pulmonary function and tissue remodeling.
Metabolic Diseases: Oxygen scarcity influences insulin resistance and metabolic changes in obesity and diabetes.
TYPES OF HYPOXIA
Hypoxic Conditions: Reduced oxygen availability in the air or lungs (e.g., high altitude).
Anemic Oxygen Deficiency: Insufficient oxygen transport due to low hemoglobin or red blood cells.
Ischemic Conditions: Restricted blood flow, preventing oxygen delivery to tissues.
Histotoxic Oxygen Impairment: Impaired cellular oxygen utilization due to toxins (e.g., cyanide poisoning).
Lee JW et al. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. (2019);51(6):1-13.
Tirpe AA et al. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. Int J Mol Sci. (2019);20(24):6140.
Yuen VW, Wong CC. Hypoxia-inducible factors and innate immunity in liver cancer.J Clin Invest. (2020);130(10):5052-5062.
Yeo EJ. Hypoxia and aging. Exp Mol Med. (2019);51(6):1-15.
Serebrovska ZO et al. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. (2020);41(12):1539-1546.